Lipid Response to Pioglitazone in Diabetic Patients: Clinical Observations from a Retrospective Chart Review

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

2001 • 24,089 citations

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

1999 • 3,464 citations

Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease

2000 • 519 citations

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study

2000 • 374 citations

Once- and Twice-Daily Dosing With Rosiglitazone Improves Glycemic Control in Patients With Type 2 Diabetes

2001 • 311 citations

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

2001 • 282 citations

Nicotinic Acid as Therapy for Dyslipidemia in Non—Insulin-Dependent Diabetes Mellitus

1990 • 278 citations

A Prospective, Randomized Comparison of the Metabolic Effects of Pioglitazone or Rosiglitazone in Patients With Type 2 Diabetes Who Were Previously Treated With Troglitazone

2002 • 254 citations

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

2001 • 221 citations

Hyperglycemic Crises in Patients With Diabetes Mellitus

2001 • 171 citations

Troglitazone Decreases the Proportion of Small, Dense LDL and Increases the Resistance of LDL to Oxidation in Obese Subjects

1998 • 138 citations

Comparison Of Effects Of Thiazolidinediones On Cardiovascular Risk Factors: Observations From A Clinical Practice

2001 • 91 citations

Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-γ

2003 • 59 citations

Effects of pioglitazone on metabolic control and blood pressure: a randomised study in patients with type 2 diabetes mellitus

2003 • 56 citations

Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus

1990 • 43 citations

VLDL Triglyceride Kinetics in Wistar Fatty Rats, An Animal Model of NIDDM: Effects of Dietary Fructose Alone or in Combination With Pioglitazone

1996 • 37 citations

The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones

2003 • 25 citations

VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone

1996 • 18 citations

Troglitazone Upregulates LDL Receptor Activity in HepG2 Cells

1998 • 14 citations

Cardiovascular Risk Factors in Childhood Diabetes

2003 • 11 citations

Dyslipidemia in Type 2 Diabetes and the Effects of Thiazolidinediones

2003 • 7 citations

Troglitazone upregulates LDL receptor activity in HepG2 cells

1998 • 7 citations